Fotivda 45629-0134-02
Generic: Tivozanib
- Manufacturer
- Aveo Pharmaceuticals, Inc.
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- March 10, 2021
- Listing Expires
- December 31, 2026
- Application
- NDA212904
Need to source Fotivda? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Tivozanib Hydrochloride | 1.34 mg/1 |
Drug Class
Kinase Inhibitor [EPC]Tyrosine Kinase Inhibitors [MoA]
Selected Package
45629-0134-02Selected1 BOTTLE, PLASTIC in 1 CARTON (45629-134-02) / 21 CAPSULE in 1 BOTTLE, PLASTIC
Other packages for this product(1)
1 BOTTLE, PLASTIC in 1 BAG (45629-134-01) / 21 CAPSULE in 1 BOTTLE, PLASTIC